Article Details
Retrieved on: 2021-08-02 07:34:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported $0.07 EPS for the quarter, topping the consensus estimate of ($0.11) by $0.18. BioMarin Pharmaceutical had a net ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here